- Home
- Publications
- Publication Search
- Publication Details
Title
Electrolyte Disorders Induced by Antineoplastic Drugs
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-19
DOI
10.3389/fonc.2020.00779
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours
- (2019) T. R. Jeffry Evans et al. BRITISH JOURNAL OF CANCER
- Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin
- (2019) Wenli Liu et al. ONCOLOGIST
- Non-steroidal anti-inflammatory drug effects on renal and cardiovascular function: from physiology to clinical practice
- (2019) Aderville Cabassi et al. European Journal of Preventive Cardiology
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
- (2018) F Cardoso et al. ANNALS OF ONCOLOGY
- Pediatric Oncologic Emergencies
- (2018) Kathleen Stephanos et al. EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
- Life-threatening Hyperkalemia Associated with Axitinib Treatment in Patients with Recurrent Renal Carcinoma: a Case Report
- (2018) Shigeo Godo et al. INTERNAL MEDICINE
- Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer
- (2018) Andreas Schneeweiss et al. INVESTIGATIONAL NEW DRUGS
- A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer
- (2018) Rie Kondo et al. ONCOLOGY
- Hyponatremia in patients with esophageal cancer treated with chemotherapy including cisplatin
- (2018) Ayako Shimada et al. Esophagus
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Extended follow-up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi-centre phase I/II Clinical Trial)
- (2018) Rakesh Popat et al. BRITISH JOURNAL OF HAEMATOLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Severity of community acquired hypernatremia is an independent predictor of mortality: a matter of water balance and rate of correction
- (2017) Aderville Cabassi et al. Internal and Emergency Medicine
- Bortezomib-induced syndrome of inappropriate antidiuresis in a patient with multiple myeloma: A case report and literature review
- (2017) Bo Peng et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
- (2017) S. Fu et al. INVESTIGATIONAL NEW DRUGS
- Syndrome of inappropriate antidiuretic hormone secretion from concomitant use of itraconazole and vindesine
- (2017) H. Zhou et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Severe Hyponatremia in a Single-Center Series of 84 Homogenously Treated Children With Acute Lymphoblastic Leukemia
- (2017) Szymon Janczar et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Adverse kidney effects of epidermal growth factor receptor inhibitors
- (2017) Hassan Izzedine et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Acute Kidney Injury in Patients with Cancer
- (2017) Mitchell H. Rosner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08‐20
- (2017) Yehuda Patt et al. ONCOLOGIST
- The Incidence of Cisplatin-induced Hypomagnesemia in Cervical Cancer Patients Receiving Cisplatin Alone
- (2017) Yoshihiro Yamamoto et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review
- (2016) Scott C. Howard et al. ANNALS OF HEMATOLOGY
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma
- (2016) Yudai Okano et al. ENDOCRINE JOURNAL
- Electrolyte disorders associated with the use of anticancer drugs
- (2016) George Liamis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hyponatremia induced by antiepileptic drugs in patients with epilepsy
- (2016) Xi Lu et al. Expert Opinion On Drug Safety
- Safety and efficacy of nivolumab in the treatment of cancers: A meta-analysis of 27 prospective clinical trials
- (2016) Yan Tie et al. INTERNATIONAL JOURNAL OF CANCER
- Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution
- (2016) Taichi Yoshida et al. International Journal of Clinical Oncology
- Late effects of chemotherapeutic agents on renal function in childhood cancer survivors: a review of the literature
- (2016) D. O’Sullivan IRISH JOURNAL OF MEDICAL SCIENCE
- Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
- (2016) Arend von Stackelberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe Hyponatremia and Immune Nephritis Following an Initial Infusion of Nivolumab
- (2016) Jeremy W. Vandiver et al. Targeted Oncology
- Incidence and physiological mechanism of carboplatin-induced electrolyte abnormality among patients with non-small cell lung cancer
- (2016) Yushui Ma et al. Oncotarget
- Tumour biomarkers: homeostasis as a novel prognostic indicator
- (2016) Michela Falco et al. Open Biology
- Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial
- (2016) Rakesh Popat et al. Lancet Haematology
- Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial
- (2016) Patrick B Johnston et al. Lancet Haematology
- Tyrosine kinase inhibitor-associated syndrome of inappropriate secretion of anti-diuretic hormone
- (2016) Jordan Hill et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials
- (2016) Rossana Berardi et al. PLoS One
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) C. Parker et al. ANNALS OF ONCOLOGY
- Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) P. Baas et al. ANNALS OF ONCOLOGY
- Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients
- (2015) Tetsuji Terazawa et al. Asia-Pacific Journal of Clinical Oncology
- Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response
- (2015) Winnie Yeo et al. BMC CANCER
- A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
- (2015) Pei-Fang Wu et al. BMC CANCER
- A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
- (2015) T Sakiyama et al. BRITISH JOURNAL OF CANCER
- Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial
- (2015) Robert J. Morgan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemia
- (2015) Yukio Kobayashi et al. CANCER SCIENCE
- Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer
- (2015) Yassine Lalami et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
- (2015) Charles J Ryan et al. LANCET ONCOLOGY
- Disorders of Plasma Sodium — Causes, Consequences, and Correction
- (2015) Richard H. Sterns NEW ENGLAND JOURNAL OF MEDICINE
- Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients
- (2015) R. Berardi et al. SUPPORTIVE CARE IN CANCER
- Ado-trastuzamab emtansine associated hyponatremia and intracranial hemorrhage
- (2014) Andrew R. Kolarich et al. ACTA ONCOLOGICA
- Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
- (2014) MarkN Stein et al. ASIAN JOURNAL OF ANDROLOGY
- Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck
- (2014) Nabil F. Saba et al. CANCER
- Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments
- (2014) Laura D. Locati et al. CANCER
- An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
- (2014) Vassiliki Saloura et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- SEOM guidelines on hydroelectrolytic disorders
- (2014) R. De las Peñas et al. Clinical & Translational Oncology
- Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology
- (2014) Davide Bolignano et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial
- (2014) Cora N Sternberg et al. LANCET ONCOLOGY
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Electrolyte disorders assessment in solid tumor patients treated with anti-EGFR monoclonal antibodies: a pooled analysis of 25 randomized clinical trials
- (2014) Qiaoli Wang et al. TUMOR BIOLOGY
- Ifosfamide-induced Fanconi syndrome with diabetes insipidus
- (2014) Ah Young Leem et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Electrolyte Disorders Associated With Cancer
- (2013) Mitchell H. Rosner et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations
- (2013) Joseph G. Verbalis et al. AMERICAN JOURNAL OF MEDICINE
- Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) M. Fruh et al. ANNALS OF ONCOLOGY
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) R. Labianca et al. ANNALS OF ONCOLOGY
- Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
- (2013) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- Skeletal and Hormonal Effects of Magnesium Deficiency
- (2013) Robert K. Rude et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration
- (2013) M. E. Rodriguez-Ortiz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The TRPM6/EGF Pathway Is Downregulated in a Rat Model of Cisplatin Nephrotoxicity
- (2013) Kristien J. Ledeganck et al. PLoS One
- The frequency, cost, and clinical outcomes of hypernatremia in patients hospitalized to a comprehensive cancer center
- (2013) Abdulla K. Salahudeen et al. SUPPORTIVE CARE IN CANCER
- Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer
- (2012) B. Besse et al. ANNALS OF ONCOLOGY
- Syndrome of Inappropriate Antidiuretic Hormone Secretion Induced by a Single Dose of Oral Cyclophosphamide
- (2012) Peter J Gilbar et al. ANNALS OF PHARMACOTHERAPY
- Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
- (2012) Susan O'Brien et al. BRITISH JOURNAL OF HAEMATOLOGY
- Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study
- (2012) Andrzej J. Jakubowiak et al. BRITISH JOURNAL OF HAEMATOLOGY
- Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents
- (2012) M. A. Perazella Clinical Journal of the American Society of Nephrology
- Diagnosis and Management of Hyponatremia in Cancer Patients
- (2012) J. J. Castillo et al. ONCOLOGIST
- Fanconi's Syndrome and Nephrogenic Diabetes Insipidus in an Adult Treated with Ifosfamide
- (2012) Amanda I. Ingemi et al. PHARMACOTHERAPY
- Hyponatremia in Hospitalized Cancer Patients and Its Impact on Clinical Outcomes
- (2011) Simit M. Doshi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implications
- (2011) O. Mir et al. ANNALS OF ONCOLOGY
- Hyponatremia Is Not a Rare Adverse Event in Bortezomib-Treated Patients
- (2011) Semra Paydas CHEMOTHERAPY
- Acute-onset hypomagnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone
- (2011) Masahiro Yamamoto et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Hyponatremia associated with Ipilimumab-induced hypophysitis
- (2011) Zachary R. Barnard et al. MEDICAL ONCOLOGY
- Cisplatin-Induced Renal Salt Wasting Syndrome
- (2011) Tamim Hamdi et al. SOUTHERN MEDICAL JOURNAL
- Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
- (2010) Ki Y. Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients
- (2010) S. Wu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fatal necrotizing pancreatitis during combined treatment with erlotinib and sunitinib
- (2010) G. Maarten-Friso Ruinemans et al. LUNG CANCER
- Insight on mechanism of hyponatraemia induced by low-dose intravenous pulse cyclophosphamide
- (2010) S. J. Park et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Medication-induced hypophosphatemia: a review
- (2010) G. Liamis et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Acquired Fanconi Syndrome After Treatment with Capecitabine, Irinotecan, and Bevacizumab
- (2009) Aisha Shaikh et al. ANNALS OF PHARMACOTHERAPY
- Dysregulation of bone remodeling by imatinib mesylate
- (2009) K. Vandyke et al. BLOOD
- Meta-analysis of incidence and risk of hypokalemia with cetuximab-based therapy for advanced cancer
- (2009) Yunfei Cao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618
- (2009) Susanne M. Arnold et al. INVESTIGATIONAL NEW DRUGS
- A review of drug-induced hypocalcemia
- (2009) George Liamis et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children
- (2009) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide
- (2009) Y. C. Lee et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Skeletal sequelae of cancer and cancer treatment
- (2009) Charles J. Stava et al. Journal of Cancer Survivorship
- Severe hyponatremia caused by hyperglycaemia due to interferon alpha therapy in advanced renal cell carcinoma
- (2008) Patricia M. M. B. Soetekouw et al. ACTA ONCOLOGICA
- Partial Fanconi Syndrome Induced by Imatinib Therapy: A Novel Cause of Urinary Phosphate Loss
- (2008) Helene François et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A Review of Drug-Induced Hyponatremia
- (2008) George Liamis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Syndrome of Inappropriate Secretion of Antidiuretic Hormone Associated with Imatinib
- (2008) Konstantinos Liapis et al. ANNALS OF PHARMACOTHERAPY
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemotherapy-Induced Nausea and Vomiting
- (2008) Paul J. Hesketh NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started